08 Oct, 2024 Introduction to the DLA Piper Genomics Series: An Insight into the ‘Genomics Revolution’ By Marion Abecassis Lyndsey Hudson Kate Black Ruth Faragher +1 more... Show less Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
15 Oct, 2024 DLA Piper Genomics Series: From crisp packets to CRISPR, and beyond By Rebecca Lawrence Genome editing is an immensely powerful tool which has the potential to revolutionise the life sciences, including medicine and...
11 Oct, 2024 England's CQC under fire: Significant failings identified in new single assessment framework By Poppy Williams Teresa Hitchcock A recent review by Dr Penny Dash, known as the 'Dash Report', has identified significant failings in England's Care Quality Commission...
07 Oct, 2024 Poland - Life Sciences Monthly Brief, September 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our September monthly briefing, which covers key updates and insights in the following areas: Medicinal products;...
03 Oct, 2024 Draft regulation on therapeutic use of cannabis in Spain By Elisa Lorenzo The Spanish Ministry of Health has made public this week the draft Royal Decree establishing the conditions for the elaboration and...
30 Sep, 2024 A New Era of Pay Transparency is Here By Katie Davies In recent years, there has been an upward global trend in the implementation of new legal measures aimed at addressing pay transparency....
24 Sep, 2024 Advertising of medical devices in CEE: discussion of legal issues By Veronika Appl Petr Samec Andrzej Balicki, Ph.D. Jolanta Dabrowicz Irina Macovei Amalia Musat +3 more... Show less Lawyers from DLA Piper’s Life Sciences team – Veronika Appl (Austria), Petr Samec (Czech Republic), Andrzej Balicki and Jolanta Dąbrowicz...
18 Sep, 2024 Brazil: Class Council Vs. Legislative Power - who should regulate the relationships between physicians and the healthcare industry? By Bruna Rocha Juliana Marcondes Victoria Cristofaro Camila Dulcine +1 more... Show less Resolution 2,386/2024 of the CFM aims to regulate the physician-healthcare industry relationship by prioritizing a transparent and...
13 Sep, 2024 Navigating the Evolving Regulatory Landscape: The Role of Strategic Partnerships in Biopharmaceuticals By Bruna Rocha Victoria Cristofaro Camila Dulcine Decoding the regulatory conundrum Biopharmaceutical companies are navigating an increasingly complex global regulatory landscape that...
11 Sep, 2024 Navigating EU and national regulatory scrutiny in so called “killer acquisitions” By Alexandra Kamerling Darach Connolly Zoltan Marosi Daniel Colgan Amanda Wait +2 more... Show less The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
09 Sep, 2024 Life Sciences News in Italy: August 2024 By DLA Piper Life Sciences Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
04 Sep, 2024 Poland - Life Sciences Monthly Brief, August 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
04 Sep, 2024 Anticorruption and anti-money laundering top the UAE’s enforcement agenda: Key takeaways for the Life Sciences Sector By Adam Vause Celia Johnson-Morgan Katie Edwards Governments around the world continue to place corporate crime at the top of their enforcement agendas, and the United Arab Emirates...
20 Aug, 2024 The potential turnaround of advertising and promotion rules for medicines in Brazil By Bruna Rocha Juliana Marcondes Victoria Cristofaro New STJ decision may redefine rules in the health sector, including RDC 96/2008 On August 14, 2024, Justice Regina Helena Costa of the...
14 Aug, 2024 Drug discovery and development in the age of AI By Rebecca Lawrence DLA Piper’s inaugural Life Sciences Index is a survey and study series about perceptions of innovation and growth in the life sciences...
14 Aug, 2024 Wearables and the rise of standard essential patents in the life sciences sector By Petros Nafpliotis Tabitha Norris The integration of advanced technologies in the life sciences sector is leading to a transformative shift in the industry as innovations...
14 Aug, 2024 An AnoxyGen-eration of new drugs? Natural products and their patentability By Tabitha Norris Georgina Doukanaris Natural products (i.e. products produced by living organisms such as plants, animals and microbes) have historically been a major...